MedPath

Effects of High-intensity Interval Training on Myocardial Strain in Metabolic Syndrome Patients

Not Applicable
Completed
Conditions
Myocardial Dysfunction
High-Intensity Interval Training
Metabolic Syndrome
Interventions
Behavioral: High-intensity interval training
Registration Number
NCT06262256
Lead Sponsor
University of Castilla-La Mancha
Brief Summary

the effects of high-intensity interval training on myocardial function will be studied in a group of patients under medical treatment for the components of metabolic syndrome.

Detailed Description

Objective: To analyze the effects of high-intensity interval training (HIIT) on myocardial function of metabolic syndrome patients.

Methods and design. Randomized clinical trial with a control group. Project was developed in association with the regional general hospital. Pre and post-intervention evaluation after 16 weeks of training for the HIIT group.

Subjects: Recruited using adverts published on public medical center boards. Up to 30 subjects per group (HIIT and CONTROL) will be recruited (at least 20% women) Measurements. Echocardiography: Global longitudinal strain (GLS), Mitral filling parameters, myocardial dimensions, and myocardial wall thickness.

Cardiorespiratory fitness: Maximal oxygen consumption, Maximal power output, Maximal oxygen pulse.

Clinical: Metabolic syndrome components and derived variables (e.g., triglycerides/high-density lipoprotein ratio) Body composition by anthropometric measurements and dual-energy X-ray absorptiometry.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Clinical diagnosis of metabolic syndrome.
  • Capacity to exercise on a stationary bike
  • Inhabitant of the province of Toledo
Exclusion Criteria
  • Untreated cardiovascular disease with hemodynamic instability
  • Untreated respiratory disease, symptomatic.
  • Untreated metabolic disease.
  • Untreated renal disease requiring dialysis.
  • Contraindications for high-intensity exercise training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-intensity interval trainingHigh-intensity interval trainingRegular medical treatment for patients with metabolic syndrome plus, 16 weeks of high-intensity interval training (3-times/week, 50 min/session conducted on stationary bike).
Primary Outcome Measures
NameTimeMethod
Changes in global longitudinal strainup to 16 weeks

response to myocardial strain after intervention. Assessed by echocardiography, measured as a percentage

Secondary Outcome Measures
NameTimeMethod
changes in cardiorespiratory fitnessup to 16 weeks

changes in maximal oxygen consumption measured in litres/min, all assessed by a cardiopulmonary exercise test in cycle-ergometer with breath by breath gas analysis.

changes in metabolic syndrome z-scoreup to 16 weeks

Adimensional variable used to assess in a unified score, the changes in the components of metabolic syndrome. The z-score is based on the cut-off points ot the components(fasting serum concentrations of glucose, triglycerides, and high density lipoprotein, all measured in mg/DL), waist circumference measured in cm, systolic and diastolic blood pressure measured in mm Hg), and the variance of each variable among participants assessed by the standard deviation.

changes in estimated left ventricle filling pressures (E/e')up to 16 weeks

changes in estimated left ventricle filling pressures by E/e' ratio (Peak E-wave velocity divided by the peak e' velocity) obtained by echocardiography, being E and e' measured in m/seg.

changes in visceral fatup to 16 weeks

changes in visceral fat after intervention, assessed by dual-energy x-ray absortiometry. Measured in kg.

changes in left ventricle passive filling (E wave)up to 16 weeks

changes in early diastolic mitral inflow velocity (E wave), assessed by echocardiography. Measured in m/seg.

changes in early diastolic mitral annulus velocity (e' wave)up to 16 weeks

changes in early diastolic mitral annulus velocity (e' wave), assessed by echocardiography. Measured in m/seg.

Trial Locations

Locations (1)

University of Castilla-La Mancha

🇪🇸

Toledo, Castilla-La Mancha, Spain

© Copyright 2025. All Rights Reserved by MedPath